Beyond gut immunity and secretion of antimicrobial molecules, MB40 could also limit the visceral spread of LM by improving systemic innate immunity, for which immunoglobulin A (IgA) is a positively correlated marker [101]. Here, CD79A is linked to lymphangioma.